drugset / Trial / NCT02078856
Double-blind, Randomised Study of A3384 in BAM/BAD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this trial is to determine the efficacy and safety of A3384 administered to patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).
Timeline
- Start
- 2014-03
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholestyramine | Other / unclassified | — | — |